Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection

Cell Reports

Volumn 16, Issue 2, 2016, Pages 432-443

  Buonomo, Erica L ^a   Cowardin, Carrie A ^a   Wilson, Madeline G ^a   Saleh, Mahmoud M ^a   Pramoonjago, Patcharin ^a   Petri, William A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COLISTIN; GENTAMICIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 25; METRONIDAZOLE; MUCIN; VANCOMYCIN; D17WSU104E PROTEIN, MOUSE; INTERLEUKIN 4; INTERLEUKIN DERIVATIVE; STOMACH MUCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CLOSTRIDIUM DIFFICILE INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EOSINOPHIL COUNT; FEMALE; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; INNATE IMMUNITY; MALE; MICROFLORA; MOLECULAR INTERACTION; MORBIDITY; MORTALITY RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; EOSINOPHIL; IMMUNOLOGY; INTESTINE FLORA; LEUKOCYTE COUNT; METABOLISM; MICROBIOLOGY; MUCOSA; PATHOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY; PROTECTION; PSEUDOMEMBRANOUS COLITIS;

ANIMALS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EOSINOPHILS; GASTRIC MUCINS; GASTROINTESTINAL MICROBIOME; HUMANS; INTERLEUKIN-4; INTERLEUKINS; LEUKOCYTE COUNT; MALE; MICE, INBRED C57BL; MUCOUS MEMBRANE; PROTECTIVE FACTORS;

EID: 84992514307     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.06.007     Document Type: Article

References (46)

1. Abt, M.C., Lewis, B.B., Caballero, S., Xiong, H., Carter, R.A., Sušac, B., Ling, L., Leiner, I., Pamer, E.G., Innate immune defenses mediated by two ILC subsets are critical for protection against acute Clostridium difficile infection. Cell Host Microbe 18 (2015), 27–37.
2. Antharam, V.C., Li, E.C., Ishmael, A., Sharma, A., Mai, V., Rand, K.H., Wang, G.P., Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 51 (2013), 2884–2892.
3. Antonopoulos, D.A., Huse, S.M., Morrison, H.G., Schmidt, T.M., Sogin, M.L., Young, V.B., Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 77 (2009), 2367–2375.
4. Britton, R.A., Young, V.B., Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 20 (2012), 313–319.
5. Britton, R.A., Young, V.B., Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 146 (2014), 1547–1553.
6. Buffie, C.G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda, C., Xavier, J., Pamer, E.G., Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect. Immun. 80 (2012), 62–73.
7. Buffie, C.G., Bucci, V., Stein, R.R., McKenney, P.T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517 (2015), 205–208.
8. Buonomo, E.L., Madan, R., Pramoonjago, P., Li, L., Okusa, M.D., Petri, W.A. Jr., Role of interleukin 23 signaling in Clostridium difficile colitis. J. Infect. Dis. 208 (2013), 917–920.
9. Chang, J.Y., Antonopoulos, D.A., Kalra, A., Tonelli, A., Khalife, W.T., Schmidt, T.M., Young, V.B., Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197 (2008), 435–438.
10. Chen, X., Katchar, K., Goldsmith, J.D., Nanthakumar, N., Cheknis, A., Gerding, D.N., Kelly, C.P., A mouse model of Clostridium difficile-associated disease. Gastroenterology 135 (2008), 1984–1992.
11. Chen, H.-H., Sun, A.-H., Ojcius, D.M., Hu, W.-L., Ge, Y.-M., Lin, X., Li, L.-J., Pan, J.-P., Yan, J., Eosinophils from murine lamina propria induce differentiation of naïve T cells into regulatory T cells via TGF-β1 and retinoic acid. PLoS ONE, 10, 2015, e0142881.
12. Cheung, P.F.Y., Wong, C.K., Ip, W.K., Lam, C.W.K., IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy 61 (2006), 878–885.
13. Chu, V.T., Beller, A., Rausch, S., Strandmark, J., Zänker, M., Arbach, O., Kruglov, A., Berek, C., Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. Immunity 40 (2014), 582–593.
14. Cowardin, C.A., Petri, W.A. Jr., Host recognition of Clostridium difficile and the innate immune response. Anaerobe 30 (2014), 205–209.
15. Cowardin, C.A., Kuehne, S.A., Buonomo, E.L., Marie, C.S., Minton, N.P., Petri, W.A. Jr., Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile. MBio, 6, 2015, e02386-14.
16. Crook, D.W., Walker, A.S., Kean, Y., Weiss, K., Cornely, O.A., Miller, M.A., Esposito, R., Louie, T.J., Stoesser, N.E., Young, B.C., et al., Study 003/004 Teams. Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clin. Infect. Dis. 55:Suppl 2 (2012), S93–S103.
17. El Feghaly, R.E., Stauber, J.L., Deych, E., Gonzalez, C., Tarr, P.I., Haslam, D.B., Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin. Infect. Dis. 56 (2013), 1713–1721.
18. El Feghaly, R.E., Stauber, J.L., Tarr, P.I., Haslam, D.B., Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections. J. Pediatr. 163 (2013), 1697–1704.e2.
19. Engevik, M.A., Engevik, K.A., Yacyshyn, M.B., Wang, J., Hassett, D.J., Darien, B., Yacyshyn, B.R., Worrell, R.T., Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile. Am. J. Physiol. Gastrointest. Liver Physiol. 308 (2015), G497–G509.
20. Fallon, P.G., Ballantyne, S.J., Mangan, N.E., Barlow, J.L., Dasvarma, A., Hewett, D.R., McIlgorm, A., Jolin, H.E., McKenzie, A.N.J., Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203 (2006), 1105–1116.
21. Ferreyra, J.A., Wu, K.J., Hryckowian, A.J., Bouley, D.M., Weimer, B.C., Sonnenburg, J.L., Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host Microbe 16 (2014), 770–777.
22. Fort, M.M., Cheung, J., Yen, D., Li, J., Zurawski, S.M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15 (2001), 985–995.
23. Franzè, E., Rizzo, A., Caruso, R., Pallone, F., Monteleone, G., Interleukin-25 negatively controls pathogenic responses in the gut. Inflamm. Allergy Drug Targets 10 (2011), 187–191.
24. Geiger, T.L., Abt, M.C., Gasteiger, G., Firth, M.A., O'Connor, M.H., Geary, C.D., O'Sullivan, T.E., van den Brink, M.R., Pamer, E.G., Hanash, A.M., Sun, J.C., Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. J. Exp. Med. 211 (2014), 1723–1731.
25. Griseri, T., Arnold, I.C., Pearson, C., Krausgruber, T., Schiering, C., Franchini, F., Schulthess, J., McKenzie, B.S., Crocker, P.R., Powrie, F., Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis. Immunity 43 (2015), 187–199.
26. Hasegawa, M., Yada, S., Liu, M.Z., Kamada, N., Muñoz-Planillo, R., Do, N., Núñez, G., Inohara, N., Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. Immunity 41 (2014), 620–632.
27. Hogan, S.P., Waddell, A., Fulkerson, P.C., Eosinophils in infection and intestinal immunity. Curr. Opin. Gastroenterol. 29 (2013), 7–14.
28. Jacobsen, E.A., Ochkur, S.I., Pero, R.S., Taranova, A.G., Protheroe, C.A., Colbert, D.C., Lee, N.A., Lee, J.J., Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J. Exp. Med. 205 (2008), 699–710.
29. Jarchum, I., Liu, M., Shi, C., Equinda, M., Pamer, E.G., Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect. Immun. 80 (2012), 2989–2996.
30. Kleinschek, M.A., Owyang, A.M., Joyce-Shaikh, B., Langrish, C.L., Chen, Y., Gorman, D.M., Blumenschein, W.M., McClanahan, T., Brombacher, F., Hurst, S.D., et al. IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 204 (2007), 161–170.
31. Lessa, F.C., Mu, Y., Bamberg, W.M., Beldavs, Z.G., Dumyati, G.K., Dunn, J.R., Farley, M.M., Holzbauer, S.M., Meek, J.I., Phipps, E.C., et al. Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 372 (2015), 825–834.
32. Linch, S.N., Danielson, E.T., Kelly, A.M., Tamakawa, R.A., Lee, J.J., Gold, J.A., Interleukin 5 is protective during sepsis in an eosinophil-independent manner. Am. J. Respir. Crit. Care Med. 186 (2012), 246–254.
33. Madan, R., Guo, X., Naylor, C., Buonomo, E.L., Mackay, D., Noor, Z., Concannon, P., Scully, K.W., Pramoonjago, P., Kolling, G.L., et al. Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis. Infect. Immun. 82 (2014), 341–349.
34. Masterson, J.C., McNamee, E.N., Fillon, S.A., Hosford, L., Harris, R., Fernando, S.D., Jedlicka, P., Iwamoto, R., Jacobsen, E., Protheroe, C., et al. Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis. Gut 64 (2015), 1236–1247.
35. Ng, K.M., Ferreyra, J.A., Higginbottom, S.K., Lynch, J.B., Kashyap, P.C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B.C., Monack, D.M., Sonnenburg, J.L., Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502 (2013), 96–99.
36. Peterson, L.W., Artis, D., Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14 (2014), 141–153.
37. Reynolds, J.M., Lee, Y.-H., Shi, Y., Wang, X., Angkasekwinai, P., Nallaparaju, K.C., Flaherty, S., Chang, S.H., Watarai, H., Dong, C., Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation. Immunity 42 (2015), 692–703.
38. Ryan, A., Lynch, M., Smith, S.M., Amu, S., Nel, H.J., McCoy, C.E., Dowling, J.K., Draper, E., O'Reilly, V., McCarthy, C., et al. A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog., 7, 2011, e1002076.
39. Saenz, S.A., Taylor, B.C., Artis, D., Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol. Rev. 226 (2008), 172–190.
40. Tang, W., Smith, S.G., Beaudin, S., Dua, B., Howie, K., Gauvreau, G., O'Byrne, P.M., IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma. Int. Arch. Allergy Immunol. 163 (2014), 5–10.
41. Travers, J., Rothenberg, M.E., Eosinophils in mucosal immune responses. Mucosal Immunol. 8 (2015), 464–475.
42. von Moltke, J., Ji, M., Liang, H.-E., Locksley, R.M., Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 529 (2016), 221–225.
43. Warren, C.A., van Opstal, E., Ballard, T.E., Kennedy, A., Wang, X., Riggins, M., Olekhnovich, I., Warthan, M., Kolling, G.L., Guerrant, R.L., et al. Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model. Antimicrob. Agents Chemother. 56 (2012), 4103–4111.
44. Wilson, K.H., Perini, F., Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect. Immun. 56 (1988), 2610–2614.
45. Zaiss, M.M., Maslowski, K.M., Mosconi, I., Guenat, N., Marsland, B.J., Harris, N.L., IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity. PLoS Pathog., 9, 2013, e1003531.
46. Zaph, C., Du, Y., Saenz, S.A., Nair, M.G., Perrigoue, J.G., Taylor, B.C., Troy, A.E., Kobuley, D.E., Kastelein, R.A., Cua, D.J., et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J. Exp. Med. 205 (2008), 2191–2198.